AstraZeneca and Lilly’s Alzheimer’s drug fails trial
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…
Researchers just published the first randomized controlled trial ever to show an intervention effective at lowering the risk of dementia.…
Amgen and Novartis said today they will expand their two-year-old collaboration with the Banner Alzheimer’s Institute by launching a new…